Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
5
×
biotech
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
startups
boston
clinical trials
fda
investing
ipo
vc
480 biomedical
acetylon pharmaceuticals
acute myeloid leukemia
alx oncology
ambys medicines
arsenal medical
autoimmune diseases
azacitidine
berkeley lights
beta-thalassemia
biopharmaceutical
biotech ipos
bob langer
business
cancer drugs
cancer immunotherapy
cd47
cell therapy
chronic kidney disease
chronic rhinosinusitis
constellation pharmaceuticals
covid-19
What
biotech
5
×
new
5
×
medicines
research
companies
company
developing
formed
ipo
markets
raised
science
startup
therapeutics
abbott
abbvie
agreement
aiming
aims
ambys
announced
approach
arrival
backed
based
big
biopharma
calico
called
center
control
countries
days
deadly
deal
debut
debuted
debuts
diseases
drugs
Language
unset
Current search:
biotech
×
new
×
deals
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@venturebeat.com
9 years ago
Google-backed Calico and Abbott Labs spinoff will set up $1.5B research center